Adult low-grade glioma

19-year experience at a single institution

Ryan S. Youland, Paul D. Brown, Caterina Giannini, Ian F Parney, Joon H. Uhm, Nadia N Laack

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objectives: To determine prognostic factors and optimal timing of postoperative radiation therapy (RT) in adult low-grade gliomas. Methods: Records from 554 adults diagnosed with nonpilocytic lowgrade gliomas at Mayo Clinic between 1992 and 2011 were retrospectively reviewed. Results: Median follow-up was 5.2 years. Histology revealed astrocytoma in 22%, oligoastrocytoma in 34%, and oligodendroglioma in 45%. Initial surgery achieved gross total resection in 31%, radical subtotal resection in 10%, subtotal resection (STR) in 21%, and biopsy only in 39%. Median overall survival (OS) and progression-free survival (PFS) were 11.4 and 4.1 years, respectively. On multivariate analysis, factors associated with lower OS included astrocytomas and use of postoperative RT. Adverse prognostic factors for PFS on multivariate analysis included tumor size, astrocytomas, STR/biopsy only and not receiving RT. Patients undergoing gross total resection/radical subtotal resection had the best OS and PFS. Comparing survival with the log-rank test demonstrated no association between RT and PFS (P = 0.24), but RT was associated with lower OS (P < 0.0001). In patients undergoing STR/biopsy only, RT was associated with improved PFS (P < 0.0001) but lower OS (P = 0.03). Postoperative RT was associated with adverse prognostic factors including age > 40 years, deep tumors, size ≥5 cm, astrocytomas and STR/biopsy only. Patients delaying RT until recurrence experienced 10-year OS (71%) similar to patients never needing RT (74%; P = 0.34).

Original languageEnglish (US)
Pages (from-to)612-619
Number of pages8
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume36
Issue number6
DOIs
StatePublished - Dec 2013

Fingerprint

Glioma
Radiotherapy
Astrocytoma
Disease-Free Survival
Survival
Biopsy
Multivariate Analysis
Oligodendroglioma
Neoplasms
Histology
Recurrence

Keywords

  • Clinical outcomes
  • Low-grade glioma
  • Prognosis
  • Radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Adult low-grade glioma : 19-year experience at a single institution. / Youland, Ryan S.; Brown, Paul D.; Giannini, Caterina; Parney, Ian F; Uhm, Joon H.; Laack, Nadia N.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 36, No. 6, 12.2013, p. 612-619.

Research output: Contribution to journalArticle

@article{b93583d2d3f1429caa3d7445e56a00a6,
title = "Adult low-grade glioma: 19-year experience at a single institution",
abstract = "Objectives: To determine prognostic factors and optimal timing of postoperative radiation therapy (RT) in adult low-grade gliomas. Methods: Records from 554 adults diagnosed with nonpilocytic lowgrade gliomas at Mayo Clinic between 1992 and 2011 were retrospectively reviewed. Results: Median follow-up was 5.2 years. Histology revealed astrocytoma in 22{\%}, oligoastrocytoma in 34{\%}, and oligodendroglioma in 45{\%}. Initial surgery achieved gross total resection in 31{\%}, radical subtotal resection in 10{\%}, subtotal resection (STR) in 21{\%}, and biopsy only in 39{\%}. Median overall survival (OS) and progression-free survival (PFS) were 11.4 and 4.1 years, respectively. On multivariate analysis, factors associated with lower OS included astrocytomas and use of postoperative RT. Adverse prognostic factors for PFS on multivariate analysis included tumor size, astrocytomas, STR/biopsy only and not receiving RT. Patients undergoing gross total resection/radical subtotal resection had the best OS and PFS. Comparing survival with the log-rank test demonstrated no association between RT and PFS (P = 0.24), but RT was associated with lower OS (P < 0.0001). In patients undergoing STR/biopsy only, RT was associated with improved PFS (P < 0.0001) but lower OS (P = 0.03). Postoperative RT was associated with adverse prognostic factors including age > 40 years, deep tumors, size ≥5 cm, astrocytomas and STR/biopsy only. Patients delaying RT until recurrence experienced 10-year OS (71{\%}) similar to patients never needing RT (74{\%}; P = 0.34).",
keywords = "Clinical outcomes, Low-grade glioma, Prognosis, Radiotherapy",
author = "Youland, {Ryan S.} and Brown, {Paul D.} and Caterina Giannini and Parney, {Ian F} and Uhm, {Joon H.} and Laack, {Nadia N}",
year = "2013",
month = "12",
doi = "10.1097/COC.0b013e31825d580a",
language = "English (US)",
volume = "36",
pages = "612--619",
journal = "American Journal of Clinical Oncology: Cancer Clinical Trials",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Adult low-grade glioma

T2 - 19-year experience at a single institution

AU - Youland, Ryan S.

AU - Brown, Paul D.

AU - Giannini, Caterina

AU - Parney, Ian F

AU - Uhm, Joon H.

AU - Laack, Nadia N

PY - 2013/12

Y1 - 2013/12

N2 - Objectives: To determine prognostic factors and optimal timing of postoperative radiation therapy (RT) in adult low-grade gliomas. Methods: Records from 554 adults diagnosed with nonpilocytic lowgrade gliomas at Mayo Clinic between 1992 and 2011 were retrospectively reviewed. Results: Median follow-up was 5.2 years. Histology revealed astrocytoma in 22%, oligoastrocytoma in 34%, and oligodendroglioma in 45%. Initial surgery achieved gross total resection in 31%, radical subtotal resection in 10%, subtotal resection (STR) in 21%, and biopsy only in 39%. Median overall survival (OS) and progression-free survival (PFS) were 11.4 and 4.1 years, respectively. On multivariate analysis, factors associated with lower OS included astrocytomas and use of postoperative RT. Adverse prognostic factors for PFS on multivariate analysis included tumor size, astrocytomas, STR/biopsy only and not receiving RT. Patients undergoing gross total resection/radical subtotal resection had the best OS and PFS. Comparing survival with the log-rank test demonstrated no association between RT and PFS (P = 0.24), but RT was associated with lower OS (P < 0.0001). In patients undergoing STR/biopsy only, RT was associated with improved PFS (P < 0.0001) but lower OS (P = 0.03). Postoperative RT was associated with adverse prognostic factors including age > 40 years, deep tumors, size ≥5 cm, astrocytomas and STR/biopsy only. Patients delaying RT until recurrence experienced 10-year OS (71%) similar to patients never needing RT (74%; P = 0.34).

AB - Objectives: To determine prognostic factors and optimal timing of postoperative radiation therapy (RT) in adult low-grade gliomas. Methods: Records from 554 adults diagnosed with nonpilocytic lowgrade gliomas at Mayo Clinic between 1992 and 2011 were retrospectively reviewed. Results: Median follow-up was 5.2 years. Histology revealed astrocytoma in 22%, oligoastrocytoma in 34%, and oligodendroglioma in 45%. Initial surgery achieved gross total resection in 31%, radical subtotal resection in 10%, subtotal resection (STR) in 21%, and biopsy only in 39%. Median overall survival (OS) and progression-free survival (PFS) were 11.4 and 4.1 years, respectively. On multivariate analysis, factors associated with lower OS included astrocytomas and use of postoperative RT. Adverse prognostic factors for PFS on multivariate analysis included tumor size, astrocytomas, STR/biopsy only and not receiving RT. Patients undergoing gross total resection/radical subtotal resection had the best OS and PFS. Comparing survival with the log-rank test demonstrated no association between RT and PFS (P = 0.24), but RT was associated with lower OS (P < 0.0001). In patients undergoing STR/biopsy only, RT was associated with improved PFS (P < 0.0001) but lower OS (P = 0.03). Postoperative RT was associated with adverse prognostic factors including age > 40 years, deep tumors, size ≥5 cm, astrocytomas and STR/biopsy only. Patients delaying RT until recurrence experienced 10-year OS (71%) similar to patients never needing RT (74%; P = 0.34).

KW - Clinical outcomes

KW - Low-grade glioma

KW - Prognosis

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84892568666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892568666&partnerID=8YFLogxK

U2 - 10.1097/COC.0b013e31825d580a

DO - 10.1097/COC.0b013e31825d580a

M3 - Article

VL - 36

SP - 612

EP - 619

JO - American Journal of Clinical Oncology: Cancer Clinical Trials

JF - American Journal of Clinical Oncology: Cancer Clinical Trials

SN - 0277-3732

IS - 6

ER -